DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA
pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or m...
Saved in:
Main Authors | , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
09.08.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders. |
---|---|
Bibliography: | Application Number: US201715709903 |